RCUS vs TECH
Arcus Biosciences Inc (RCUS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported RCUS revenue for 2024-12-31 was $258.0M. Net income was -$283.0M. Revenue was up 120.5% from 2023-12-31 to 2024-12-31. RCUS currently screens at market cap $885.2M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
RCUS currently screens at market cap $885.2M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the RCUS and TECH stock pages for the full models.
Not investment advice.